Pharmaceutical Industry

  • Wholesale Pharmaceutical Provider Recycled $100 Million of Black Market Drugs

    The owner and operator of a Utah wholesale pharmaceutical distributor has been found to have utilized the black market to reap over $16 million in illicit profits during his two-year scheme. The ploy was conceived and executed through his company, Green Valley Medical Distributors LLC, a supposed intermediary between pharmaceutical manufacturers and pharmacies. In reality, […]

  • AstraZeneca and Medco: A Powerful (and Dishonest) Alliance

    Following a whistleblower suit, pharmaceutical manufacturer AstraZeneca agreed to pay $7.9 million to resolve claims that stated their engagement in a massive kickback scheme with a distributor, offering remuneration in exchange for inappropriate marketing of their popular drug Nexium. The alleged relationship involved a pharmacy benefit manager formerly known as Medco (now ExpressScripts), who was […]

  • Celgene Pays $280 Million for Off-Label Marketing of Cancer Drugs

    Celgene, a pharmaceutical manufacturer based out of New Jersey, paid $280 million following a whistleblower suit which claimed they promoted their popular cancer drugs for unapproved purposes. The two drugs in question, Thalomid and Revlimid, are Celgene’s highest-grossing products, together accounting for $8.4 billion in annual revenue – an astounding 75% of the company’s profits. […]

  • Pharma Monster Mylan Dodges Medicaid, Violates False Claims Act

    In August of 2017, the massive pharmaceutical conglomerate Mylan underwent allegations that they deliberately violated the False Claims Act in order to avoid paying Medicaid rebates, resulting in a $465 million settlement. According to the Department of Justice, the company misclassified their pioneer drug, EpiPen, as a generic in order to avoid paying appropriate Medicaid […]